WallStSmart

The Hackett Group Inc (HCKT)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

The Hackett Group Inc generates 16% more annual revenue ($300.85M vs $258.90M). HCKT leads profitability with a 4.3% profit margin vs -15.5%. HCKT earns a higher WallStSmart Score of 57/100 (C).

HCKT

Buy

57

out of 100

Grade: C

Growth: 5.3Profit: 6.0Value: 7.3Quality: 5.0

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

HCKTUndervalued (+21.5%)

Margin of Safety

+21.5%

Fair Value

$18.31

Current Price

$13.49

$4.82 discount

UndervaluedFair: $18.31Overvalued
ZEPPUndervalued (+48.8%)

Margin of Safety

+48.8%

Fair Value

$46.82

Current Price

$17.47

$29.35 discount

UndervaluedFair: $46.82Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HCKT2 strengths · Avg: 9.0/10
EPS GrowthGrowth
64.6%10/10

Earnings expanding 64.6% YoY

PEG RatioValuation
0.708/10

Growing faster than its price suggests

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

HCKT4 concerns · Avg: 3.0/10
P/E RatioValuation
29.3x4/10

Moderate valuation

Market CapQuality
$340.22M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
4.3%3/10

4.3% margin — thin

Revenue GrowthGrowth
-3.4%2/10

Revenue declined 3.4%

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : HCKT

The strongest argument for HCKT centers on EPS Growth, PEG Ratio. PEG of 0.70 suggests the stock is reasonably priced for its growth.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : HCKT

The primary concerns for HCKT are P/E Ratio, Market Cap, Profit Margin. Thin 4.3% margins leave little buffer for downturns.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

HCKT profiles as a value stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor INFORMATION TECHNOLOGY SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

HCKT scores higher overall (57/100 vs 41/100). ZEPP offers better value entry with a 48.8% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

The Hackett Group Inc

TECHNOLOGY · INFORMATION TECHNOLOGY SERVICES · USA

The Hackett Group, Inc. is a technology consulting and strategic advisory firm primarily in North America and internationally. The company is headquartered in Miami, Florida.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?